Rearrangement of p53 gene with overexpressed p53 protein in primary cervical cancer

Oncology Reports

Volumn 9, Issue 2, 2002, Pages 433-437

  Sahu, Geeta Ram ^a   Nayak, Bijaya Kumar ^a   Patnaik, Srinivas ^a   Parija, Tithi ^a   Das, Bibhu Ranjan ^a  

^a INSTITUTE OF LIFE SCIENCES   (India)

Author keywords

Cervical cancer; p53 mutation; p53 overexpression; Rearrangement

Indexed keywords

DNA; PROTEIN P53;

ARTICLE; CANCER STAGING; ENZYME IMMUNOASSAY; FEMALE; GENE REARRANGEMENT; GENETICS; HUMAN; METABOLISM; PATHOLOGY; POINT MUTATION; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

BLOTTING, SOUTHERN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; GENE REARRANGEMENT; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM STAGING; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 0036514436     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.2.433     Document Type: Article

References (44)

1. Hollstein M, Sidransky D, Vogelstein B and Harris C: p53 mutation in human cancers. Science 253: 49-53, 1991.
2. Harris C: Structure and function of the p53 tumour suppressor genes: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442-1455, 1996.
3. Offner S, Schmaus W, Witter K, Baretton B, Gustavo BB, Schlimok G, Passlick B, Riethmuller G and Pantel K: p53 gene mutations are not required for early dissemination of cancer cells. Proc Natl Acad Sci USA 96: 6942-6946, 1999. (Pubitemid 29274989)
4. Levine AJ: p53, the cellular gatekeeper of growth and division. Cell 88: 323-331, 1997.
5. Agarwal LM, Agarwal A, Taylor RW, Chernova O, Sharma Y and Stark RG: A p53-dependent S-phase checkpoint helps to Drotect cells from DNA damage in response to starvation for pyrimidine nucleotides. Proc Natl Acad Sci USA 95: 14775-14780, 1998. (Pubitemid 29003706)
6. Ko LJ and Prives C: p53: puzzle and paradigm. Genes Dev 10: 1054-1072, 1996. (Pubitemid 26152848)
7. Zhang Q, Qutsch D and Kenney S: Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol Cell Biol 14: 1929-1938, 1994. (Pubitemid 24074588)
8. Seol WD, Chen Q, Smith LM and Zarnegar R: Regulation of the c-met proto-oncogene promoter by p53. J Biol Chem 274: 3565-3572, 1999. (Pubitemid 29077198)
9. Ray RB, Steele R, Meyer K and Ray R: Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 272: 10983-10986, 1997. (Pubitemid 27184081)
10. Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM and Latchman DS: p53 suppresses the activation of the BCL-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem 274: 15237-15244, 1999.
11. Lane DP: P53, guardian of the genome. Nature 358: 15-16, 1992.
12. Greenblatt MS, Bennel WP, Hollstein M and Harris C: Mutations in the p53 tumour supressor genes: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994. (Pubitemid 24289415)
13. Nayak BK, Baral RN and Das BR: p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer. Neoplasma 43: 305-310, 1996. (Pubitemid 26387199)
14. Masuda H, Miller C, Koeffler HP, Baflifora H and Cline M: Rearrangement of p53 gene in human osteosarcomas. Proc Natl Acad Sci USA 84: 7716-7719, 1987. (Pubitemid 18035728)
15. Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF and Minna JD: p53: a frequent for genetic abnormalities in lung cancer. Science 246: 491-494, 1989. (Pubitemid 19273938)
16. Nayak BK, Patnaik S and Das BR: Rearrangement of the p53 gene in human breast tumours. Biochem Biophys Res Commun 245: 388-391, 1998. (Pubitemid 28418510)
17. Patnaik S, Nayak BK and Das BR: Rearrangement in the coding and 5′ region of p53 gene in human oral tumours. IUBMB Life 48: 305-309, 1999. (Pubitemid 29517384)
18. Crook T and Vousden KH: Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J 11: 3935-3940, 1992.
19. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ and Vousden KH : Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus- negative tumours. Lancet 339: 1070-1073, 1992.
20. Fujita M, Inoue M, Tanizawa O, Iwamoto S and Enomoto T: Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 52: 5323-5328, 1992.
21. Blin N and Stafford DW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3: 2303, 1976.
22. Hayashi K: A simple and sensitive method for dection of mutations in the genomic DNA. PCR Methods Applications 1: 34-38, 1991.
23. Lamb P and Crawford L: Characterization of human p53 gene. Mol Cell Biol 6: 1379-1385, 1986.
24. Auffray C and Rougeon O: Purification of mouse immunoglobin heavy chain messanger RNAs from total myeloma tumour RNA. Eur J Biochem 107: 303-314, 1980.
25. Schreiber E, Maftihas P, Muller MM and Schaftner W: Rapid detection of octamer binding proteins with 'mini-extracts' prepared from a small number of cells. Nucleic Acids Res 17: 6419, 1989. (Pubitemid 19198635)
26. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
27. Herrero R: Epidemiology of cervical cancer. J Natl Cancer Inst Monogr21: 1-6, 1996.
28. Tenti P, Pavanello S, Padovan L, Spinillo A, Vesntini N, Zappatore R, Migliora P, Zara C, Ranzani GN and Carnevali L: Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix. Am J Pathol 152: 1057-1063, 1998. (Pubitemid 28173367)
29. Nakagawa S, Yoshikawa H, Jimbo H, Onda T, Yasugi T, Matsumoto K, Kino N, Kawana K, Kozuka T, Nakagawa K, Aoki M and Takenati Y: Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations. Br J Cancer 79: 1139-1144, 1999. (Pubitemid 29087887)
30. Gostout BS, Podratz KC, McGovern RM and Persing DH: Cervical cancer in older women: a molecular analysis of human papillomavirus types, HLA types and p53 mutations. Am J Obstet Gynecol 179: 56-61, 1998. (Pubitemid 28394473)
31. Kim JW, Cho YH, Lee CG, Kim JH, Kim HK, Kim EJ, Han KT and Namkoong SE: Human papillomavirus infection and TP53 gene mutations in primary cervical carcinoma. Acta Oncol 36: 295-300, 1997. (Pubitemid 27232331)
32. Miwa K, Miyamoto S, Kato H, Imamura T, Nishida M, Yoshikawa Y, Nagata Y and Wake N: The role of p53 in human cervical cell carcinoma development. Br J Cancer 71: 219-226, 1995.
33. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M and Loning T: Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer 63: 639-645, 1995.
34. Helland A, Karlsen F, Due EU, Holm R, Kristensen G and Borresen-Dale AI: Mutations in the TP53 gene and protein expression of p53, mdm2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus lead. Br J Cancer 78: 69-72, 1998. (Pubitemid 28276772)
35. Munirajan AK, Kannan K, Bhuvarahamurthy V, Ishida I, Fujinaga K, Tsuchida N and Shanmugam G: The status of human papillomavirus and tumour suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Gynecol Oncol 69: 205-209, 1998. (Pubitemid 28289960)
36. Nagan HY, Tsao SW, Liu SS and Stanley M: Abnormal expression and mutation of p53 in cervical cancer, a study at protein, RNA and DNA levels. Genitourin Med 73: 54-58, 1997. (Pubitemid 27076089)
37. Benjamin I, Saigo P, Finstand C, Jakahashi H, Federici M, Rubin SC and Boyol J: Expression and mutational analysis of p53 in stage IB and IIA cervical cancers. Am J Obstet Gynecol 175: 1266-1271, 1996. (Pubitemid 26398989)
38. Waggoner SE, Anderson SM, Luce MC, Takahashi H and Boyol J: p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol 60: 339-344, 1996. (Pubitemid 26077615)
39. Castren K, Vahakangas K, Heikkinen E and Ranki A: Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein. Int J Cancer 31: 674-678, 1998. (Pubitemid 28341381)
40. Ahuja H, Bar-Eli M, Advani SH, Benchimol S and Cime MJ: Alteration of p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci USA 86: 6783-6787, 1989. (Pubitemid 19236343)
41. Feinstein E, Cimino G, Gale RP, Alimena G, Berthier R, Kishi K, Goldman J, Zaccaria A, Berrebi A and Canaai E: p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci USA 88: 6293-6297, 1991. (Pubitemid 21914932)
42. Marasca R, Luppi M, Barozzi P, Ferrari MG, Morselli M and Torelli G: p53 gene mutations in chronic myelogenous leukemia, medullary and extramedullar blast crisis. Leuk Lymphoma 24: 175-182, 1996.
43. Wolf D and Rotter V: Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequence. Mol Cell Biol 4: 1402-1410, 1984. (Pubitemid 16242538)
44. Ruscetti SK and Scolnick EM: Expression of transformation related protein (p53) in the malignant stage of Friend virus-induced disease. J Virol 46: 1022-1026, 1983. (Pubitemid 13092510)